TEL AVIV, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that it has entered into an agreement with JKI, established by the fund managed and operated by J-Will, whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva Takeda Yakuhin Ltd. will…
Mon, 07 Apr 2025 12:30:00 GMT To learn more about how Teva is all in for better health, visit www.tevapharm.com. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within ...
Mon, 07 Apr 2025 10:58:00 GMT To learn more about how Teva is all in for better health, visit www.tevapharm.com. This press release contains forward-looking statements within the meaning of the Private Securities Litigation ...
Mon, 07 Apr 2025 04:30:00 GMT To learn more about how Teva is all in for better health, visit www.tevapharm.com. Cautionary Note Regarding Forward-Looking StatementsThis press release contains forward-looking statements within ...
Thu, 03 Apr 2025 17:00:00 GMT TEVA) announced today that it will issue a press release on its first quarter 2025 financial results on Wednesday, May 7, 2025, at 7:00 a.m. ET. Following the release, Teva will conduct a conference ...
